| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/19/2011 | US7928089 Mucoactive agents for treating a pulmonary disease |
| 04/19/2011 | US7928088 Th1 cell differentiation accelerator |
| 04/19/2011 | US7928087 provides a flow texture to cosmetic compositions and are easily rinsed; Hair treated with the composition has a soft feel free of residue; used for washing and/or conditioning keratinous matter such as hair or skin |
| 04/19/2011 | US7928086 β-L-2′-deoxynucleosides for the treatment of resistant HBV strains and combination therapies |
| 04/19/2011 | US7928085 P-toluene sulfonic acid salt of 5-amino-3-(2′-O-acetyl-3′-deoxy-β-D-ribofuranosyl)-3H-thiazole[4,5-d]pyrimidine-2-one and methods for preparation |
| 04/19/2011 | US7928084 Regulation of integrin surface expression |
| 04/19/2011 | US7928083 H19 silencing nucleic acid agents for treating rheumatoid arthritis |
| 04/19/2011 | US7928082 Bispecific antisense oligonucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using same |
| 04/19/2011 | US7928081 Combined use of PRAME inhibitors and HDAC inhibitors |
| 04/19/2011 | US7928080 Indole antiviral compositions and methods |
| 04/19/2011 | US7928079 Polysaccharide-derived nitric oxide-releasing carbon-bound diazeniumdiolates |
| 04/19/2011 | US7928078 Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy |
| 04/19/2011 | US7928077 Alpha-galactosyl ceramide analogs and their use as immunotherapies |
| 04/19/2011 | US7928073 Purified polypeptides having IL-13 receptor activity |
| 04/19/2011 | US7928071 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 04/19/2011 | US7928070 Administering protein kinase C |
| 04/19/2011 | US7928069 Crosslinked compounds and methods of making and using thereof |
| 04/19/2011 | US7928065 Methods of treatment using exendin peptides or GLP-1 peptides |
| 04/19/2011 | US7928062 inhibiting or disrupting Janus tyrosine kinase 3 (Jak3) dependent function in cells of lymphoid or myeloid origin, especially for blocking proliferation and function of lymphocytes (e.g., T-cells, B-cells). A Mannich base compound, or a derivative or modified |
| 04/19/2011 | US7928056 Enzyme treatment of foodstuffs for Celiac Sprue |
| 04/19/2011 | US7927873 Polyamides for nucleic acid delivery |
| 04/19/2011 | US7927862 Production of isoprenoids |
| 04/19/2011 | US7927861 Production of isoprenoids |
| 04/19/2011 | US7927806 Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues |
| 04/19/2011 | US7927793 Cell lines and host nucleic acid sequences related to infectious disease |
| 04/19/2011 | US7927792 Targeted double stranded RNA mediated cell killing |
| 04/19/2011 | US7927636 Hydroxycitric acid compositions, pharmaceutical and dietary supplements and food products made therefrom, and methods for their use in reducing body weight |
| 04/19/2011 | US7927633 Adaptogenic tea |
| 04/19/2011 | US7927631 extracts from herbal varieties: Polygonum multiflorum, Panax quinquefolium, Gingko biloba, and Equisetum arvense; beta sitosterol methyl sulfonyl methane; soy isoflavones; levo-arginine; inositol; niacin; pantothenic acid; alpha-tocopherol; biotin; pyridoxine hydrochloride zinc and colostrum |
| 04/19/2011 | US7927627 Nanoparticulate fibrate formulations |
| 04/19/2011 | US7927624 Hydrophilic/lipophilic polymeric matrix dosage formulation |
| 04/19/2011 | US7927623 Pleasant taste; bioabsorbable; overcoated water insoluble drug in alcohol solvent and water soluble binder; mixing, compression |
| 04/19/2011 | US7927621 Thioester-ester-amide copolymers |
| 04/19/2011 | US7927619 In situ bulking composition |
| 04/19/2011 | US7927612 Combinations and methods for treating neoplasms |
| 04/19/2011 | US7927609 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 04/19/2011 | US7927543 Method of treating a marine object |
| 04/19/2011 | CA2640482C Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them |
| 04/19/2011 | CA2628963C Benzene derivative or salt thereof |
| 04/19/2011 | CA2625563C Dihydrogen phosphate salt of a prostaglandin d2 receptor antagonist |
| 04/19/2011 | CA2624788C Improved testosterone gel and method of use |
| 04/19/2011 | CA2621181C 5-isoquinolinesulfonamide compounds |
| 04/19/2011 | CA2610637C Use of agomelatine to obtain drugs intended for the treatment of periventricular leukomalacia |
| 04/19/2011 | CA2601289C Once-a-day oxycodone formulations |
| 04/19/2011 | CA2596241C Methods and pharmaceutical compositions useful for treating neurological disorders |
| 04/19/2011 | CA2591257C Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
| 04/19/2011 | CA2578047C Phenylaminopyridines |
| 04/19/2011 | CA2571133C Fused benzamide compound and vanilloid receptor 1 (vr1) activity inhibitor |
| 04/19/2011 | CA2560417C 1,2-diarylimidazole-4-carboxamide derivatives |
| 04/19/2011 | CA2553704C Substituted benzimidazoles and their use for inducing apoptosis |
| 04/19/2011 | CA2539853C Isoquinolinone potassium channel inhibitors |
| 04/19/2011 | CA2539476C Quinazoline potassium channel inhibitors |
| 04/19/2011 | CA2538546C Polymorphic forms of rifaximin, processes for their production and use thereof in medicinal preparations |
| 04/19/2011 | CA2529669C Method for measuring aromatase activity |
| 04/19/2011 | CA2516643C Method for preparing polymorphism of irinotecan hydrochloride |
| 04/19/2011 | CA2507572C Levalbuterol salt |
| 04/19/2011 | CA2503570C Remedy for overactive bladder comprising acetic acid anilide derivative as the active ingredient |
| 04/19/2011 | CA2499523C Therapeutic agents and corresponding treatments |
| 04/19/2011 | CA2499006C Formulation which can be administered gastrointestinally, and the use thereof |
| 04/19/2011 | CA2486495C 9-alpha-substituted estratrienes as selectively active estrogens |
| 04/19/2011 | CA2476012C Substituted pyridinones as modulators of p38 map kinase |
| 04/19/2011 | CA2474674C Solid preparation containing single crystal form |
| 04/19/2011 | CA2464951C Spirocyclic 3-phenyl-3-substituted-4-ketolactams and -lactones |
| 04/19/2011 | CA2464000C 2-phenyl benzimidazoles and imidazo-[4,5]-pyridines as cdsi/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer |
| 04/19/2011 | CA2462338C Powder processing with pressurized gaseous fluids |
| 04/19/2011 | CA2459087C Synthesis of ester linked long chain alkyl moieties |
| 04/19/2011 | CA2458452C Gnrh agonist combination drugs |
| 04/19/2011 | CA2452577C Soft capsules |
| 04/19/2011 | CA2450946C Use of branched-chain fatty acids and derivatives thereof for the treatment of pain |
| 04/19/2011 | CA2445048C Preparations containing afamin for treating oxidative stress-induced neurogenerative disease |
| 04/19/2011 | CA2441099C Proanthocyanidins for the treatment of amyloid and alpha-synuclein diseases |
| 04/19/2011 | CA2440557C Combinations of heparin cofactor ii agonist and platelet iib/iiia antagonist, and uses thereof |
| 04/19/2011 | CA2421258C Truncated bard1 protein, and its diagnostic and therapeutic uses |
| 04/19/2011 | CA2400969C Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response to measles vaccine |
| 04/19/2011 | CA2400886C Novel galenical form for oral administration with prolonged release of molsidomine |
| 04/19/2011 | CA2393802C 3-aminoquinazolin-2,4-dione antibacterial agents |
| 04/19/2011 | CA2384417C Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 04/19/2011 | CA2378778C Il-16 antagonists |
| 04/19/2011 | CA2362496C Polypeptide variants with increased heparin-binding ability |
| 04/19/2011 | CA2319599C Delivery of immunogenic molecules via hbsag particles |
| 04/19/2011 | CA2295625C Imidazole derivatives as mdr modulators |
| 04/19/2011 | CA2264276C Process for preparing fat or oil containing unsaturated fatty acid |
| 04/19/2011 | CA2251746C Oxa diacids and related compounds for treating skin conditions |
| 04/19/2011 | CA2226301C Natural or synthetic retroelement sequence enabling nucleotide sequence insertion into a eukaryotic cell |
| 04/19/2011 | CA2220116C Dna encoding glutamate gated chloride channels |
| 04/19/2011 | CA2208245C Purification of a triple helix formation with an immobilized oligonucleotide |
| 04/16/2011 | CA2777223A1 2h-pyrrol-5-amine derivatives as alpha adrenergic receptor modulators |
| 04/16/2011 | CA2735344A1 A novel formulation for treating fungal infections |
| 04/14/2011 | WO2011044587A2 Cytoprotective or therapeutic plant composition |
| 04/14/2011 | WO2011044568A1 Topical skin cream |
| 04/14/2011 | WO2011044540A1 Topical formulation comprising etoricoxib and a zwitterionic surfactant |
| 04/14/2011 | WO2011044538A1 Antibacterial aminoglycoside analogs |
| 04/14/2011 | WO2011044537A2 Methods for treating alzheimer's disease |
| 04/14/2011 | WO2011044535A2 8-ethyl-6-(aryl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders |
| 04/14/2011 | WO2011044523A2 Compositions and methods for treating obesity |
| 04/14/2011 | WO2011044506A2 Sulphone compounds and methods of making and using same |
| 04/14/2011 | WO2011044505A2 Enzyme inhibiting compounds and methods |
| 04/14/2011 | WO2011044504A1 Modulating levels of rna-binding proteins for the treatment of breast cancer |
| 04/14/2011 | WO2011044503A1 Antibacterial aminoglycoside analogs |
| 04/14/2011 | WO2011044502A1 Antibacterial aminoglycoside analogs |